US Stock MarketDetailed Quotes

MIST Milestone Pharmaceuticals

Watchlist
  • 1.870
  • +0.020+1.08%
Close Nov 27 16:00 ET
99.72MMarket Cap-2337P/E (TTM)

Milestone Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
0
0
0
-80.00%1M
0
0
0
1M
-66.67%5M
3.5M
Operating revenue
--0
--0
--0
-80.00%1M
--0
--0
--0
--1M
-66.67%5M
--3.5M
Cost of revenue
Gross profit
Operating expense
-37.40%9.62M
-41.21%9.66M
-36.52%10.48M
-3.94%62.1M
-20.04%13.8M
-7.08%15.36M
-2.20%16.44M
17.48%16.5M
11.31%64.64M
2.02%17.26M
Selling and administrative expenses
-34.56%5.65M
-12.38%6.85M
9.48%6.84M
25.12%31.05M
24.95%8.35M
28.86%8.64M
27.08%7.81M
18.30%6.25M
27.89%24.81M
11.31%6.68M
-Selling and marketing expense
-56.69%1.91M
-46.54%1.8M
22.41%2.88M
66.18%15.11M
94.57%4.98M
65.24%4.41M
51.01%3.37M
44.01%2.36M
29.87%9.1M
15.49%2.56M
-General and administrative expense
-11.47%3.74M
13.52%5.05M
1.65%3.95M
1.36%15.93M
-18.24%3.37M
4.78%4.23M
13.45%4.45M
6.75%3.89M
26.77%15.72M
8.87%4.12M
Research and development costs
-41.04%3.96M
-67.35%2.82M
-64.52%3.64M
-22.04%31.05M
-48.46%5.45M
-31.60%6.72M
-19.10%8.62M
16.98%10.26M
2.99%39.83M
-3.10%10.58M
Operating profit
37.40%-9.62M
41.21%-9.66M
32.42%-10.48M
-2.44%-61.1M
-0.30%-13.8M
-2.20%-15.36M
2.20%-16.44M
-10.36%-15.5M
-38.47%-59.64M
18.67%-13.76M
Net non-operating interest income expense
-36.56%177K
-23.92%299K
-77.90%122K
12.68%1.41M
-67.53%189K
-41.14%279K
148.73%393K
1,280.00%552K
470.00%1.25M
1,611.76%582K
Non-operating interest income
-3.57%1.08M
-2.23%1.19M
69.91%994K
216.35%3.97M
79.73%1.05M
136.29%1.12M
667.72%1.21M
1,362.50%585K
470.00%1.25M
1,611.76%582K
Non-operating interest expense
7.37%903K
8.17%887K
2,542.42%872K
--2.55M
--857K
--841K
--820K
--33K
--0
--0
Other net income (expense)
Income before tax
37.41%-9.44M
41.64%-9.36M
30.74%-10.35M
-2.22%-59.69M
-3.29%-13.61M
-3.61%-15.08M
3.63%-16.04M
-6.73%-14.95M
-36.25%-58.39M
21.96%-13.18M
Income tax
Net income
37.41%-9.44M
41.64%-9.36M
30.74%-10.35M
-2.22%-59.69M
-3.29%-13.61M
-3.61%-15.08M
3.63%-16.04M
-6.73%-14.95M
-36.25%-58.39M
21.96%-13.18M
Net income continuous Operations
37.41%-9.44M
41.64%-9.36M
30.74%-10.35M
-2.22%-59.69M
-3.29%-13.61M
-3.61%-15.08M
3.63%-16.04M
-6.73%-14.95M
-36.25%-58.39M
21.96%-13.18M
Minority interest income
Net income attributable to the parent company
37.41%-9.44M
41.64%-9.36M
30.74%-10.35M
-2.22%-59.69M
-3.29%-13.61M
-3.61%-15.08M
3.63%-16.04M
-6.73%-14.95M
-36.25%-58.39M
21.96%-13.18M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
37.41%-9.44M
41.64%-9.36M
30.74%-10.35M
-2.22%-59.69M
-3.29%-13.61M
-3.61%-15.08M
3.63%-16.04M
-6.73%-14.95M
-36.25%-58.39M
21.96%-13.18M
Basic earnings per share
60.00%-0.14
62.16%-0.14
40.00%-0.21
-0.72%-1.39
-3.23%-0.32
-2.94%-0.35
5.13%-0.37
-6.06%-0.35
-35.29%-1.38
22.50%-0.31
Diluted earnings per share
60.00%-0.14
62.16%-0.14
40.00%-0.21
-0.72%-1.39
-3.23%-0.32
-2.94%-0.35
5.13%-0.37
-6.06%-0.35
-35.29%-1.38
22.50%-0.31
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue 000-80.00%1M0001M-66.67%5M3.5M
Operating revenue --0--0--0-80.00%1M--0--0--0--1M-66.67%5M--3.5M
Cost of revenue
Gross profit
Operating expense -37.40%9.62M-41.21%9.66M-36.52%10.48M-3.94%62.1M-20.04%13.8M-7.08%15.36M-2.20%16.44M17.48%16.5M11.31%64.64M2.02%17.26M
Selling and administrative expenses -34.56%5.65M-12.38%6.85M9.48%6.84M25.12%31.05M24.95%8.35M28.86%8.64M27.08%7.81M18.30%6.25M27.89%24.81M11.31%6.68M
-Selling and marketing expense -56.69%1.91M-46.54%1.8M22.41%2.88M66.18%15.11M94.57%4.98M65.24%4.41M51.01%3.37M44.01%2.36M29.87%9.1M15.49%2.56M
-General and administrative expense -11.47%3.74M13.52%5.05M1.65%3.95M1.36%15.93M-18.24%3.37M4.78%4.23M13.45%4.45M6.75%3.89M26.77%15.72M8.87%4.12M
Research and development costs -41.04%3.96M-67.35%2.82M-64.52%3.64M-22.04%31.05M-48.46%5.45M-31.60%6.72M-19.10%8.62M16.98%10.26M2.99%39.83M-3.10%10.58M
Operating profit 37.40%-9.62M41.21%-9.66M32.42%-10.48M-2.44%-61.1M-0.30%-13.8M-2.20%-15.36M2.20%-16.44M-10.36%-15.5M-38.47%-59.64M18.67%-13.76M
Net non-operating interest income expense -36.56%177K-23.92%299K-77.90%122K12.68%1.41M-67.53%189K-41.14%279K148.73%393K1,280.00%552K470.00%1.25M1,611.76%582K
Non-operating interest income -3.57%1.08M-2.23%1.19M69.91%994K216.35%3.97M79.73%1.05M136.29%1.12M667.72%1.21M1,362.50%585K470.00%1.25M1,611.76%582K
Non-operating interest expense 7.37%903K8.17%887K2,542.42%872K--2.55M--857K--841K--820K--33K--0--0
Other net income (expense)
Income before tax 37.41%-9.44M41.64%-9.36M30.74%-10.35M-2.22%-59.69M-3.29%-13.61M-3.61%-15.08M3.63%-16.04M-6.73%-14.95M-36.25%-58.39M21.96%-13.18M
Income tax
Net income 37.41%-9.44M41.64%-9.36M30.74%-10.35M-2.22%-59.69M-3.29%-13.61M-3.61%-15.08M3.63%-16.04M-6.73%-14.95M-36.25%-58.39M21.96%-13.18M
Net income continuous Operations 37.41%-9.44M41.64%-9.36M30.74%-10.35M-2.22%-59.69M-3.29%-13.61M-3.61%-15.08M3.63%-16.04M-6.73%-14.95M-36.25%-58.39M21.96%-13.18M
Minority interest income
Net income attributable to the parent company 37.41%-9.44M41.64%-9.36M30.74%-10.35M-2.22%-59.69M-3.29%-13.61M-3.61%-15.08M3.63%-16.04M-6.73%-14.95M-36.25%-58.39M21.96%-13.18M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 37.41%-9.44M41.64%-9.36M30.74%-10.35M-2.22%-59.69M-3.29%-13.61M-3.61%-15.08M3.63%-16.04M-6.73%-14.95M-36.25%-58.39M21.96%-13.18M
Basic earnings per share 60.00%-0.1462.16%-0.1440.00%-0.21-0.72%-1.39-3.23%-0.32-2.94%-0.355.13%-0.37-6.06%-0.35-35.29%-1.3822.50%-0.31
Diluted earnings per share 60.00%-0.1462.16%-0.1440.00%-0.21-0.72%-1.39-3.23%-0.32-2.94%-0.355.13%-0.37-6.06%-0.35-35.29%-1.3822.50%-0.31
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data